NCT06251973 2025-12-02A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction CancerMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting37 enrolled